Furthermore, one pathway of resistance to EGFR inhibitors in EGFR over-expressing/Delta-EGFR glioblastomas is represented by phosphorylation of PTEN at tyrosine 240 [127]. The gene discussed is EGFR; the disease is glioblastoma.